References
1. Ciofalo A, Gulotta G, Iannella G, Pasquariello B, Manno A, Angeletti
D, et al. Giant Cell Arteritis (GCA): Pathogenesis, Clinical Aspects and
Treatment Approaches. Curr Rheumatol Rev. 2019;15(4):259–68.
2. Bevan AT, Dunnill MS, Harrison MJ. Clinical and biopsy findings in
temporal arteritis. Ann Rheum Dis. 1968 May;27(3):271–7.
3. Lyons HS, Quick V, Sinclair AJ, Nagaraju S, Mollan SP. A new era for
giant cell arteritis. Eye Lond Engl. 2020 Jun;34(6):1013–26.
4. Ling ML, Yosar J, Lee BW, Shah SA, Jiang IW, Finniss A, et al. The
diagnosis and management of temporal arteritis. Clin Exp Optom. 2020
Sep;103(5):572–82.
5. Hernández-Rodríguez J, Murgia G, Villar I, Campo E, Mackie SL,
Chakrabarty A, et al. Description and Validation of Histological
Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in
Giant-cell Arteritis. Medicine (Baltimore). 2016 Feb;95(8):e2368.
6. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH,
et al. The American College of Rheumatology 1990 criteria for the
classification of giant cell arteritis. Arthritis Rheum. 1990
Aug;33(8):1122–8.
7. Chatelain D, Duhaut P, Schmidt J, Loire R, Bosshard S, Guernou M, et
al. Pathological features of temporal arteries in patients with giant
cell arteritis presenting with permanent visual loss. Ann Rheum Dis.
2009 Jan;68(1):84–8.
8. Makkuni D, Bharadwaj A, Wolfe K, Payne S, Hutchings A, Dasgupta B. Is
intimal hyperplasia a marker of neuro-ophthalmic complications of giant
cell arteritis? Rheumatol Oxf Engl. 2008 Apr;47(4):488–90.
9. Brekke LK, Diamantopoulos AP, Fevang BT, Aβmus J, Esperø E, Gjesdal
CG. Incidence of giant cell arteritis in Western Norway 1972-2012: a
retrospective cohort study. Arthritis Res Ther. 2017 Dec 15;19(1):278.
10. Nesher G. The diagnosis and classification of giant cell arteritis.
J Autoimmun. 2014 Mar;48–49:73–5.